These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27821613)

  • 21. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
    Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
    J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
    Hapgood JP
    AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
    Akello CA; Bunge KE; Nakabiito C; Mirembe BG; Fowler MG; Mishra A; Marrazzo J; Chirenje ZM; Celum C; Balkus JE
    J Womens Health (Larchmt); 2017 Jun; 26(6):670-676. PubMed ID: 28437215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
    Front Immunol; 2021; 12():760504. PubMed ID: 34956191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N; Bahamondes L; Bahamondes MV; Bottura BF; Monteiro I
    Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
    AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers MR; Nichols S; Levy B
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.
    Sabo MC; Richardson BA; Lavreys L; Martin HL; Jaoko W; Mandaliya K; Baeten JM; Overbaugh J; McClelland RS
    AIDS; 2019 Jun; 33(7):1225-1230. PubMed ID: 31048629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
    Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L; Denny L; Wright TC; Kuhn L
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
    Ralph LJ; Gollub EL; Jones HE
    Curr Opin Obstet Gynecol; 2015 Dec; 27(6):487-95. PubMed ID: 26536211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.
    Chohan V; Baeten JM; Benki S; Graham SM; Lavreys L; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J; McClelland RS
    Sex Transm Infect; 2009 Dec; 85(7):489-92. PubMed ID: 19457873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
    Boodhram R; Moodley D; Abbai N; Ramjee G
    BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results.
    Okegbe T; Affo J; Djihoun F; Zannou A; Hounyo O; Ahounou G; Bangbola KA; Harris N
    Glob Health Sci Pract; 2019 Jun; 7(2):228-239. PubMed ID: 31171559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects.
    Liu J; Shen J; Diamond-Smith N
    Contraception; 2018 Nov; 98(5):430-437. PubMed ID: 29733817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
    Sonalkar S; McClusky J; Hou MY; Borgatta L
    Contraception; 2015 Feb; 91(2):174-7. PubMed ID: 25481376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.
    Clark MK; Dillon JS; Sowers M; Nichols S
    Int J Obes (Lond); 2005 Oct; 29(10):1252-8. PubMed ID: 15997247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.